TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07265349: A Phase I/II Clinical Trial to Evaluate the Safety and Efficacy of Intramyocardial Injection of Human Umbilical Cord Mesenchymal Stem Cells (HucMSCs) Combined With Coronary Artery Bypass Grafting in the Treatment of Chro

Sponsor: Tasly Pharmaceutical Group Co., Ltd · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 51 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$4,769,180

Rescue Site Savings

+$3,160,640

Unlock Full NCT07265349 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07265349 Rescue Dossier →